37 results

• Dupixent Lawyers Seek Leadership Positions in MDL Over Cancer Risks

  October 1, 2026

  Irvin Jackson

  Plaintiffs propose that about a dozen attorneys be appointed to leadership positions in the growing Dupixent cancer litigation.

• Dupixent Side Effects Lawsuit Alleges Drug Caused Cutaneous T-Cell Lymphoma

  September 24, 2026

  Irvin Jackson

  A woman's Dupixent cancer lawsuit alleges that the manufacturers should have known the eczema treatment caused a rare form of T-cell lymphoma and warned doctors and patients.

• Dupixent Side Effects Caused CTCL, Tumors, Lawsuit Alleges

  September 10, 2026

  Irvin Jackson

  A Dupixent CTCL lawsuit claims using the eczema treatment led to a man's cancer returning, leaving him with life-long medical treatment needs.

• Dupixent Lymphoma Lawsuit Alleges Atopic Dermatitis Drug Led to Mycosis Fungoides Diagnosis

  August 20, 2026

  Irvin Jackson

  A California woman's Dupixent lymphoma lawsuit claims the manufacturers knew of the eczema drug's cancer risks, but refused to inform doctors and patients.

• Dupixent CTCL Studies Highlighted Cancer Risks For Years, Lawsuit Alleges

  August 11, 2026

  Irvin Jackson

  A Dupixent CTCL lawsuit indicates manufacturers have long known the eczema treatment was linked to an increased cancer risk, but failed to warn doctors or patients.

• CTCL Lawsuit Alleges Diagnosis Came After Less Than a Year of Dupixent Use

  July 29, 2026

  Irvin Jackson

  A Dupixent CTCL lawsuit claims that the manufacturer intentionally failed to warn patients or the medical community about the eczema treatment's potential cancer risks.

• Lawsuit Alleges Dupixent Caused Mycosis Fungoides Diagnosis

  July 21, 2026

  Irvin Jackson

  A Dupixent cancer lawsuit claims the manufacturers failed to adequately test and label the eczema treatment, resulting in a CTCL cancer diagnosis.

• Dupixent MDL Judge To Meet With Lawyers for Initial Case Management Conference in October 2026

  June 25, 2026

  Irvin Jackson

  A federal judge has scheduled the first Dupixent lawsuit MDL initial case management conference for October 1, 2026.

• Lawsuit Claims Dupixent Cancer Diagnosis Occurred After Only 8 Months of Use

  June 17, 2026

  Irvin Jackson

  The makers of Dupixent face a CTCL lawsuit by a man who says he developed the rare form of cancer less than a year after beginning treatment with the eczema drug.

• Dupixent Injection Lawsuits Consolidated in MDL Over CTCL Diagnoses

  June 9, 2026

  Irvin Jackson

  The U.S. Judicial Panel on Multidistrict Litigation has consolidated all Dupixent lawsuits in the District of New Jersey for pretrial proceedings.